NasdaqGS - Delayed Quote USD

Shattuck Labs, Inc. (STTK)

10.59 +0.81 (+8.28%)
At close: 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,657.00
1,657.00
652.00
30,017.00
9,934.00
Operating Expense
93,614.00
93,614.00
103,981.00
75,286.00
46,865.00
Operating Income
-91,957.00
-91,957.00
-103,329.00
-45,269.00
-36,931.00
Net Non Operating Interest Income Expense
4,669.00
4,669.00
1,592.00
625.00
549.00
Other Income Expense
-10.00
-10.00
-208.00
-330.00
-221.00
Pretax Income
-87,298.00
-87,298.00
-101,945.00
-44,974.00
-36,603.00
Net Income Common Stockholders
-87,298.00
-87,298.00
-101,945.00
-44,974.00
-36,603.00
Diluted NI Available to Com Stockholders
-87,298.00
-87,298.00
-101,945.00
-44,974.00
-36,603.00
Basic EPS
-2.05
--
-2.41
-1.07
-2.36
Diluted EPS
-2.05
--
-2.41
-1.07
-2.36
Basic Average Shares
42,600.19
--
42,378.90
42,032.38
15,506.07
Diluted Average Shares
42,600.19
--
42,378.90
42,032.38
15,506.07
Total Operating Income as Reported
-91,957.00
-91,957.00
-103,329.00
-45,269.00
-36,931.00
Total Expenses
93,614.00
93,614.00
103,981.00
75,286.00
46,865.00
Net Income from Continuing & Discontinued Operation
-87,298.00
-87,298.00
-101,945.00
-44,974.00
-36,603.00
Normalized Income
-87,298.00
-87,298.00
-101,945.00
-44,974.00
-36,603.00
Interest Income
4,669.00
4,669.00
1,592.00
625.00
549.00
Net Interest Income
4,669.00
4,669.00
1,592.00
625.00
549.00
EBIT
-91,957.00
-91,957.00
-103,329.00
-45,269.00
-36,931.00
EBITDA
-87,915.00
-87,915.00
-100,256.00
-43,889.00
-36,313.00
Reconciled Depreciation
4,042.00
4,042.00
3,073.00
1,380.00
618.00
Net Income from Continuing Operation Net Minority Interest
-87,298.00
-87,298.00
-101,945.00
-44,974.00
-36,603.00
Normalized EBITDA
-87,915.00
-87,915.00
-100,256.00
-43,889.00
-36,313.00
12/31/2020 - 10/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FHTX Foghorn Therapeutics Inc.
5.49
+4.97%
 
ALXO ALX Oncology Holdings Inc.
16.86
-0.06%
 
TRML Tourmaline Bio, Inc.
15.68
-2.00%
 
ANRO Alto Neuroscience, Inc.
14.18
+0.35%
 
PRLD Prelude Therapeutics Incorporated
4.0700
+0.74%
 
CCCC C4 Therapeutics, Inc.
6.17
-1.12%
 
HLVX HilleVax, Inc.
12.79
+6.41%
 
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
 
VIGL Vigil Neuroscience, Inc.
2.7100
+5.04%
 
STOK Stoke Therapeutics, Inc.
12.41
+6.16%